The Future of NASH Treatment Is Shaped by REZDIFFRA

adicionou um novo artigo Health

2025-03-07 07:12:03

A Breakthrough for NASH Patients The approval of Rezdiffra (resmetirom) marks a groundbreaking moment in the ongoing fight against Nonalcoholic Steatohepatitis (NASH), a chronic liver condition affecting millions worldwide. NASH, a progressive form of nonalcoholic fatty liver disease, is characterized by inflammation and damage to the liver, often leading to cirrhosis or liver failure....

0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior